Vanda Pharmaceuticals (VNDA) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 351.00 |
| Dec 31, 2025 | 278.00 |
| Sep 30, 2025 | 453.00 |
| Jun 30, 2025 | 420.00 |
| Mar 31, 2025 | 194.00 |
| Dec 31, 2024 | 535.00 |
| Sep 30, 2024 | 605.00 |
| Jun 30, 2024 | 537.00 |
| Mar 31, 2024 | 347.00 |
| Dec 31, 2023 | 304.00 |
| Sep 30, 2023 | 242.00 |
| Jun 30, 2023 | 341.00 |
| Mar 31, 2023 | 282.00 |
| Dec 31, 2022 | 115.00 |
| Sep 30, 2022 | 127.00 |
| Jun 30, 2022 | 136.00 |
| Mar 31, 2022 | 129.00 |
| Dec 31, 2021 | 462.00 |
| Sep 30, 2021 | 847.00 |
| Jun 30, 2021 | 835.00 |
| Mar 31, 2021 | 828.00 |
| Dec 31, 2020 | 990.00 |
| Sep 30, 2020 | 1,319.00 |
| Jun 30, 2020 | 1,151.00 |
| Mar 31, 2020 | 1,366.00 |
| Dec 31, 2019 | -578.00 |
| Sep 30, 2019 | -665.00 |
| Jun 30, 2019 | -896.00 |
| Dec 31, 2015 | -1,938.00 |
| Sep 30, 2015 | -2,297.00 |
| Jun 30, 2015 | 7,741.00 |